Long-term persistence of serum-specific anti-chikungunya IgM antibody - a case series of brazilian patients

18Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

The persistence of serum-specific anti-chikungunya IgM antibodies (CHIKV-IgM) can vary after chikungunya fever (CHIK) infection. However, the factors related to its production are not yet known. We described a case series drawn up from data collected from 57 patients between 12 and 36 months after the acute phase of CHIK infection in Northeastern Brazil. CHIKV-IgM was detectable in 7/57 (12.3%) patients after 28.3 months of infection. No frequency differences in chronic musculoskeletal manifestations and underlying conditions were detected between patients with or without CHIKV-IgM. CHIKV-IgM was detected for up to 35 months in Brazilian patients after CHIK infection.

Cite

CITATION STYLE

APA

Do Nascimento Costa, D. M., Coêlho, M. R. C. D., Da Cruz Gouveia, P. A., Bezerra, L. A., Marques, C. D. L., Duarte, A. L. B. P., … Da Silveira, V. M. (2021). Long-term persistence of serum-specific anti-chikungunya IgM antibody - a case series of brazilian patients. Revista Da Sociedade Brasileira de Medicina Tropical, 54. https://doi.org/10.1590/0037-8682-0855-2020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free